In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...